CollPlant Biotechnologies Ltd.

5.83+0.0851+1.48%Vol 8.07K1Y Perf -15.02%
Oct 4th, 2023 15:23 DELAYED
BID5.75 ASK5.85
Open5.75 Previous Close5.74
Pre-Market- After-Market5.69
 - -  -0.15 -2.49%
Target Price
17.00 
Analyst Rating
Strong Buy 1.00
Potential %
191.60 
Finscreener Ranking
★★★★+     56.21
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+     44.62
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★     57.60
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
16.08 
Earnings Rating
Strong Buy
Market Cap65.24M 
Earnings Date
24th Aug 2023
Alpha-0.02 Standard Deviation0.21
Beta0.29 

Today's Price Range

5.665.83

52W Range

4.2713.97

5 Year PE Ratio Range

-300.90-3.90

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
2.59%
1 Month
-16.38%
3 Months
-27.55%
6 Months
-22.16%
1 Year
-15.02%
3 Years
-27.55%
5 Years
14.67%
10 Years
-

TickerPriceChg.Chg.%
CLGN5.830.08511.48
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
14.30
14.80
0.06
0.08
-1 873.30
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
-60.80
-2 944.60
-2 762.10
-624.30
1.16
RevenueValueIndustryS&P 500US Markets
241.00K
0.02
23.45
99.98
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.350.49240.00
Q01 2023-0.29-0.33-13.79
Q04 2022-0.21-0.39-85.71
Q03 2022-0.31-0.40-29.03
Q02 2022-0.08-0.39-387.50
Q01 2022-0.14-0.36-157.14
Q04 2021-0.26-0.30-15.38
Q03 2021-0.28-0.29-3.57
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.0285.71Positive
12/2023 QR-0.42-800.00Negative
12/2023 FY0.97182.91Positive
12/2024 FY-0.40-66.67Negative
Next Report Date-
Estimated EPS Next Report-0.34
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume8.07K
Shares Outstanding11.19K
Shares Float8.80M
Trades Count62
Dollar Volume46.48K
Avg. Volume13.57K
Avg. Weekly Volume10.73K
Avg. Monthly Volume14.34K
Avg. Quarterly Volume15.66K

CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) stock closed at 5.7449 per share at the end of the most recent trading day (a 0.61% change compared to the prior day closing price) with a volume of 1.72K shares and market capitalization of 65.24M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 38 people. CollPlant Biotechnologies Ltd. CEO is Yehiel Tal.

The one-year performance of CollPlant Biotechnologies Ltd. stock is -15.02%, while year-to-date (YTD) performance is -31.2%. CLGN stock has a five-year performance of 14.67%. Its 52-week range is between 4.27 and 13.97, which gives CLGN stock a 52-week price range ratio of 16.08%

CollPlant Biotechnologies Ltd. currently has a PE ratio of 70.10, a price-to-book (PB) ratio of 3.43, a price-to-sale (PS) ratio of 329.12, a price to cashflow ratio of 15.50, a PEG ratio of -, a ROA of -37.90%, a ROC of -36.01% and a ROE of -42.40%. The company’s profit margin is 1.16%, its EBITDA margin is -2 762.10%, and its revenue ttm is $241.00 Thousand , which makes it $0.02 revenue per share.

Of the last four earnings reports from CollPlant Biotechnologies Ltd., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.34 for the next earnings report. CollPlant Biotechnologies Ltd.’s next earnings report date is -.

The consensus rating of Wall Street analysts for CollPlant Biotechnologies Ltd. is Strong Buy (1), with a target price of $17, which is +191.60% compared to the current price. The earnings rating for CollPlant Biotechnologies Ltd. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CollPlant Biotechnologies Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CollPlant Biotechnologies Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 25.17, ATR14 : 0.37, CCI20 : -67.96, Chaikin Money Flow : -0.18, MACD : -0.32, Money Flow Index : 12.57, ROC : -16.13, RSI : 38.61, STOCH (14,3) : 19.59, STOCH RSI : 1.00, UO : 49.54, Williams %R : -80.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CollPlant Biotechnologies Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd is a regenerative medicine company. It is focused on developing and commercializing tissue repair products, initially for 3D-bio printing of tissues and organs, dermal fillers for aesthetics, orthobiologics, and advanced wound care markets. Its products are based on recombinant human collagen produced from genetically-modified tobacco plants, and the company focuses on orthopedics and advanced wound care.

CEO: Yehiel Tal

Telephone: +972 732325600

Address: 4 Oppenheimer Street, Rehovot 7670104, , IL

Number of employees: 38

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

56%44%

Bearish Bullish

55%45%

 

News

Stocktwits